These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8233627

  • 21. [Fluoroquinolone susceptibility of Pseudomonas aeruginosa strains isolated from clinical materials].
    Wydmuch Z, Pacha J, Kepa M, Wojtyczka RD, Idzik D, Skowronek-Ciołek O, Głab S, Góras-Zawiazalec A.
    Med Dosw Mikrobiol; 2003; 55(2):165-71. PubMed ID: 14577196
    [Abstract] [Full Text] [Related]

  • 22. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
    Jung R, Fish DN, Obritsch MD, MacLaren R.
    J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239
    [Abstract] [Full Text] [Related]

  • 23. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
    Sidorenko SV, Gel'fand EB, Mamontova OA.
    Anesteziol Reanimatol; 1999 Jun; (3):46-54. PubMed ID: 10458038
    [Abstract] [Full Text] [Related]

  • 24. [Tricentric study of the sensitivity of Pseudomonas aeruginosa serotyping to beta-lactams and aminoglycosides].
    Vachée A, Scheftel JM, Husson MO, Izard D, Ross P, Monteil H.
    Pathol Biol (Paris); 1997 May; 45(5):357-62. PubMed ID: 9296084
    [Abstract] [Full Text] [Related]

  • 25. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fischer I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C.
    J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
    [Abstract] [Full Text] [Related]

  • 26. [In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
    Miguères ML, Ronco E, Guenounou M.
    Pathol Biol (Paris); 1990 May; 38(5):385-9. PubMed ID: 2195447
    [Abstract] [Full Text] [Related]

  • 27. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa.
    Al-Jasser AM, Elkhizzi NA.
    Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211
    [Abstract] [Full Text] [Related]

  • 28. [Optimization of antibiotics in combination].
    Zhang LH, Wang LF, Meng ZY, Yu QP, Gao BQ, Ba T, Wang XD, Ma WH, Li YY, Zhang J.
    Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):93-6. PubMed ID: 18785405
    [Abstract] [Full Text] [Related]

  • 29. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
    Dubrous P, Cavallo JD, Hernandez E, Nordmann P, Fabre R.
    Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
    [Abstract] [Full Text] [Related]

  • 30. [Present status of the sensitivity of Pseudomonas aeruginosa to aminoglycosides in France].
    Thabaut A, Meyran M.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):621-4. PubMed ID: 3095779
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J, Gieburowska R, Dzierzanowska D.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [Abstract] [Full Text] [Related]

  • 32. The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department.
    Thabet L, Memmi M, Turki A, Messadi AA.
    Tunis Med; 2010 May; 88(5):297-300. PubMed ID: 20517823
    [Abstract] [Full Text] [Related]

  • 33. Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
    Plasencia V, Borrell N, Maciá MD, Moya B, Pérez JL, Oliver A.
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2574-81. PubMed ID: 17470655
    [Abstract] [Full Text] [Related]

  • 34. [Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance].
    Bert F, Briaud I, Branger C, Lambert-Zechovsky N.
    Pathol Biol (Paris); 1996 May; 44(5):329-32. PubMed ID: 8758469
    [Abstract] [Full Text] [Related]

  • 35. [Choice of a rapidly bactericidal beta-lactamin-aminoglycoside combination in the treatment of Pseudomonas aeruginosa infections at a child intensive care unit].
    Lambert-Zechovsky N, Bingen E, Guihaire E, Mancy C, Mercier JC, Beaufils F.
    Pathol Biol (Paris); 1986 Sep; 34(7):855-8. PubMed ID: 3537930
    [Abstract] [Full Text] [Related]

  • 36. Simple method to determine beta-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test.
    Vedel G.
    J Antimicrob Chemother; 2005 Oct; 56(4):657-64. PubMed ID: 16144872
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    Mendes C, Hsiung A, Kiffer C, Oplustil C, Sinto S, Mimica I, Zoccoli C, Mystic Study Group.
    Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
    [Abstract] [Full Text] [Related]

  • 38. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study.
    Cavallo JD, Hocquet D, Plesiat P, Fabre R, Roussel-Delvallez M, GERPA (Groupe d'Etude de la Résistance de Pseudomonas aeruginosa aux antibiotiques).
    J Antimicrob Chemother; 2007 May; 59(5):1021-4. PubMed ID: 17412726
    [Abstract] [Full Text] [Related]

  • 39. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ, Wang H, China Nosocomial Pathogens Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):375-81. PubMed ID: 12820912
    [Abstract] [Full Text] [Related]

  • 40. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
    Thabaut A, Durosoir JL, Meyran M.
    Pathol Biol (Paris); 1982 Jun 10; 30(6 Pt 2):549-54. PubMed ID: 6812006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.